EMG
CNCE

ETF Managers Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

ETF Managers Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-31,327
Closed -$152K – 814
2021
Q1 		$152K Buy
31,327
+4,329
+16% +$35K ﹤0.01% 627
2020
Q4 		$342K Buy
+26,998
New +$308K 0.01% 529

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

ETF Managers Group's CNCE Position: Q2 2021 in Review

ETF Managers Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 31,327 shares — an estimated $152K sold.

ETF Managers Group first reported a position in CNCE in Q4 2020 and held it in 2 quarters. The position peaked at $342K in Q4 2020. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • ETF Managers Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • ETF Managers Group sold 31,327 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $152K.
  • ETF Managers Group first reported a position in Concert Pharmaceuticals, Inc. in Q4 2020 and held it in 2 quarters.
  • ETF Managers Group's Concert Pharmaceuticals, Inc. position peaked at $342K in Q4 2020.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.